Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Medicine|October 1, 2019
Clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fractionTaiki Nishihara, Eiichiro Yamamoto, Daisuke Sueta, et al.
International Journal of Cardiology. Heart & Vasculature|July 9, 2020
The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fractionTakashi Komorita, Eiichiro Yamamoto, Daisuke Sueta, et al.
Journal of Cardiac Failure|August 14, 2020
Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fractionTaiki Nishihara, Takanori Tokitsu, Daisuke Sueta, et al.
International Journal of Cardiology|November 29, 2021
Increased soluble programed cell death-ligand 1 is associated with acute coronary syndromeKoichiro Fujisue, Eiichiro Yamamoto, Daisuke Sueta, et al.
The Korean Journal of Internal Medicine|December 21, 2021
HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fractionKoichi Egashira, Daisuke Sueta, Takashi Komorita, et al.
Medicine|July 16, 2019
Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fractionKoichiro Fujisue, Takanori Tokitsu, Eiichiro Yamamoto, et al.
International Journal of Cardiology|June 9, 2020
Clinical significance of diastolic late mitral annular velocity in heart failure with preserved ejection fractionFumi Oike, Eiichiro Yamamoto, Daisuke Sueta, et al.
Journal of the American Heart Association|March 18, 2021
Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart FailureTaiki Nishihara, Eiichiro Yamamoto, Daisuke Sueta, et al.
American Journal of Hypertension|May 16, 2019
Clinical Significance of Brachial-Ankle Pulse Wave Velocity in Patients With Heart Failure With Reduced Left Ventricular Ejection FractionMasafumi Takae, Eiichiro Yamamoto, Takanori Tokitsu, et al.
International Journal of Cardiology|September 4, 2018
Coronary blood flow volume change is negatively associated with platelet aggregability in patients with non-obstructive ischemic heart disease who have no anti-platelet agentsMasafumi Takae, Eiichiro Yamamoto, Koichiro Fujisue, et al.
Pageof 3